Improved input parameters for diffusion models of skin absorption

Advanced Drug Delivery Reviews

Volumn 65, Issue 2, 2013, Pages 251-264

  Hansen, Steffi ^a,b   Lehr, Claus Michael ^a,b   Schaefer, Ulrich F ^b  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Corneocyte; Diffusion coefficient; Keratin; Lipid bilayer; Partition coefficient; Stratum corneum

Indexed keywords

CORNEOCYTE; DERMAL ABSORPTION; DIFFUSION MODEL; EXPERIMENTAL METHODS; INPUT PARAMETER; KERATIN; MODEL GEOMETRY; NON-AQUEOUS; PARTITION COEFFICIENT; PHYSICO-CHEMICALS; SKIN ABSORPTION; SLOW EQUILIBRATION; SOLUTE PROPERTIES; STRATUM CORNEUM; TRANSPORT CHARACTERISTICS;

APPROXIMATION THEORY; ESTIMATION; LIPID BILAYERS; PARAMETER ESTIMATION; PROTEINS;

DIFFUSION;

1 NAPHTHOL; ALDOSTERONE; CAFFEINE; ESTRADIOL; FLUFENAMIC ACID; HYDROCORTISONE; LIDOCAINE; LIPID; PROGESTERONE; TESTOSTERONE; THEOPHYLLINE;

ACCURACY; DIFFUSION; DIFFUSION COEFFICIENT; GEOMETRY; MATHEMATICAL ANALYSIS; PARTITION COEFFICIENT; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; SKIN ABSORPTION; SKIN PERMEABILITY; STRATUM CORNEUM;

ADMINISTRATION, CUTANEOUS; BIOLOGICAL TRANSPORT; DATABASES, FACTUAL; DIFFUSION; HUMANS; LIPIDS; MODELS, THEORETICAL; SKIN; SKIN ABSORPTION; SOLUBILITY; WATER;

EID: 84873522044     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2012.04.011     Document Type: Review

References (109)

1. Kruese J., Golden D., Wilkinson S., Williams F., Kezic S., Corish J. Analysis, interpretation, and extrapolation of dermal permeation data using diffusion-based mathematical models. J. Pharm. Sci. 2007, 96:682-703.
2. Frasch H.F., Barbero A.M. The transient dermal exposure: theory and experimental examples using skin and silicone membranes. J. Pharm. Sci. 2008, 97:1578-1592.
3. Kasting G.B. Kinetics of finite dose absorption through skin 1. Vanillylnonanamide. J. Pharmaceut. Sci. 2001, 90:202-212.
4. Kasting G.B., Miller M.A. Kinetics of finite dose absorption through skin 2: Volatile compounds. J. Pharm. Sci. 2006, 95:268-280.
5. Kalia Y.N., Pirot F., Guy R.H. Homogeneous transport in a heterogeneous membrane: water diffusion across human stratum corneum in vivo. Biophys. J. 1996, 71:2692-2700.
6. Watkinson A.C., Bunge A.L., Hadgraft J., Naik A. Computer simulation of penetrant concentration-depth profiles in the stratum corneum. Int. J. Pharm. 1992, 87:175-182.
7. Anissimov Y.G., Roberts M.S. Diffusion modeling of percutaneous absorption kinetics. 3. Variable diffusion and partition coefficients, consequences for stratum corneum depth profiles and desorption kinetics. J. Pharm. Sci. 2004, 93:470-487.
8. Cross S.E., Magnusson B.M., Winckle G., Anissimov Y., Roberts M.S. Determination of the effect of lipophilicity on the in vitro permeability and tissue reservoir characteristics of topically applied solutes in human skin layers. J. Invest. Dermatol. 2003, 120:759-764.
9. Tojo K., Chiang C.C., Chien Y.W. Drug permeation across the skin: effect of penetrant hydrophilicity. J. Pharm. Sci. 1987, 76:123-126.
10. Henning A., Neumann D., Kostka K.H., Lehr C.M., Schaefer U.F. Influence of human skin specimens consisting of different skin layers on the result of in vitro permeation experiments. Skin Pharmacol. Physiol. 2008, 21:81-88.
11. Michaels A.S., Chandrasekaran S.K., Shaw J.E. Drug permeation through human skin: theory and in vitro experimental measurement. Am. Inst. Chem. Eng. 1975, 21:985-996.
12. Wang T.F., Kasting G.B., Nitsche J.M. A multiphase microscopic diffusion model for stratum corneum permeability. I. Formulation, solution, and illustrative results for representative compounds. J. Pharm. Sci. 2006, 95:620-648.
13. Tang H., Blankschtein D., Langer R. Prediction of steady-state skin permeabilities of polar and nonpolar permeants across excised pig skin based on measurements of transient diffusion: characterization of hydration effects on the skin porous pathway. J. Pharm. Sci. 2002, 91:1891-1907.
14. Nitsche J.M., Wang T.F., Kasting G.B. A two-phase analysis of solute partitioning into the stratum corneum. J. Pharm. Sci. 2006, 95:649-666.
15. Chandrasekaran S.K., Campbell P.S., Watanabe T. Application of the "dual sorption" model to drug transport through skin. Polymer Eng. Sci. 1980, 20:36-39.
16. Kubota K., Koyama E., Twizell E.H. Dual sorption model for the nonlinear percutaneous permeation kinetics of timolol. J. Pharm. Sci. 1993, 82:1205-1208.
17. Gumel A.B., Kubota K., Twizell E.H. A sequential algorithm for the non-linear dual-sorption model of percutaneous drug absorption. Math. Biosci. 1998, 152:87-103.
18. George K. A two-dimensional mathematical model of non-linear dual-sorption of percutaneous drug absorption. Biomed. Eng. Online 2005, 4.
19. Rim J.E., Pinsky P.M., Van Osdol W.W. Finite element modeling of coupled diffusion with partitioning in transdermal drug delivery. Ann. Biomed. Eng. 2005, 33:1422-1438.
20. Manitz R., Lucht W., Strehmel K., Weiner R., Neubert R. On mathematical modeling of dermal and transdermal drug delivery. J. Pharm. Sci. 1998, 87:873-879.
21. Anissimov Y.G., Roberts M.S. Diffusion modeling of percutaneous absorption kinetics. 1. Effects of flow rate, receptor sampling rate, and viable epidermal resistance for a constant donor concentration. J. Pharm. Sci. 1999, 88:1201-1209.
22. Anissimov Y.G., Roberts M.S. Diffusion modeling of percutaneous absorption kinetics: 2. Finite vehicle volume and solvent deposited solids. J. Pharm. Sci. 2001, 90:504-520.
23. Ibrahim R., Kasting G.B. Improved method for determining partition and diffusion coefficients in human dermis. J. Pharm. Sci. 2010, 99:4928-4939.
24. Khalil E., Kretsos K., Kasting G.B. Glucose partition coefficient and diffusivity in the lower skin layers. Pharm. Res. 2006, 23:1227-1234.
25. Hansen S., Henning A., Naegel A., Heisig M., Wittum G., Neumann D., Kostka K.H., Zbytovska J., Lehr C.M., Schaefer U.F. In-silico model of skin penetration based on experimentally determined input parameters. Part I: Experimental determination of partition and diffusion coefficients. Eur. J. Pharm. Biopharm. 2008, 68:352-367.
26. Raykar P.V., Fung M.-C., Anderson B.D. The role of protein and lipid domains in the uptake of solutes by human stratum corneum. Pharm. Res. 1988, 5:140-150.
27. Hansen S., Naegel A., Heisig M., Wittum G., Neumann D., Kostka K.H., Meiers P., Lehr C.M., Schaefer U.F. The role of corneocytes in skin transport revised - a combined computational and experimental approach. Pharm. Res. 2009, 26:1379-1397.
28. Henning A., Neumann D., Kostka K.-H., Lehr C.-M., Schaefer U.F. Influence of human skin specimens consisting of different skin layers on the result of in vitro permeation experiments. Skin Pharmacol. Physiol. 2008, 21:81-88.
29. Henning A., Schaefer U.F., Neumann D. Potential pitfalls in skin permeation experiments: influence of experimental factors and subsequent data evaluation. Eur. J. Pharm. Biopharm. 2008, 324-331.
30. Mitragotri S., Anissimov Y.G., Bunge A.L., Frasch H.F., Guy R.H., Hadgraft J., Kasting G.B., Lane M.E., Roberts M.S. Mathematical models of skin permeability: an overview. Int. J. Pharm. 2011, 418:115-129.
31. Pirot F., Kalia Y.N., Stinchcomb A.L., Keating G., Bunge A., Guy R.H. Characterization of the permeability barrier of human skin in vivo. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:1562-1567.
32. Crank J. The Mathematics of Diffusion 1976, Clarendon Press, Oxford. 2nd ed.
33. Frasch H.F., Barbero A.M., Hettick J.M., Nitsche J.M. Tissue binding affects the kinetics of theophylline diffusion through the stratum corneum barrier layer of skin. J. Pharm. Sci. 2011, 100:2989-2995.
34. Anissimov Y.G., Roberts M.S. Diffusion modelling of percutaneous absorption kinetics: 4. Effects of a slow equilibration process within stratum corneum on absorption and desorption kinetics. J. Pharm. Sci. 2009, 98:772-781.
35. Scheuplein R.J. Mechanism of percutaneous absorption. II. Transient diffusion and the relative importance of various routes of skin penetration. J. Invest. Dermatol. 1967, 48:79-88.
36. Naegel A., Hansen S., Neumann D., Lehr C.M., Schaefer U.F., Wittum G., Heisig M. In-silico model of skin penetration based on experimentally determined input parameters. Part II: mathematical modelling of in-vitro diffusion experiments. Identification of critical input parameters. Eur. J. Pharm. Biopharm. 2008, 68:368-379.
37. Matheson L.E., Wurster D.E., Ostrenga J.A. Sarin transport across excised human skin II: effect of solvent pretreatment on permeability. J. Pharm. Sci. 1979, 68:1410-1413.
38. Wurster D.E., Ostrenga J.A., Matheson L.E. Sarin transport across excised human skin I: permeability and adsorption characteristics. J. Pharm. Sci. 1979, 68:1406-1409.
39. Schwindt D.A., Wilhelm K.P., Maibach H.I. Water diffusion characteristics of human stratum corneum at different anatomical sites in vivo. J. Invest. Dermatol. 1998, 111:385-389.
40. Blank I.H., Moloney J., Emslie A.G., Simon I., Apt C. The diffusion of water across the stratum corneum as a function of its water content. J. Invest. Dermatol. 1984, 82:188-194.
41. El-Shimi A.F., Princen H.M. Diffusion characteristics of water vapor in some keratins. Colloid and Polymer Sci. 1978, 256:209-217.
42. El-Shimi A.F., Princen H.M. Water vapor sorption and desorption behavior of some keratins. Colloid and Polymer Sci. 1978, 256:105-114.
43. Gunt H.B., Kasting G.B. Equilibrium water sorption characteristics of the human nail. J. Cosmet. Sci. 2007, 58:1-9.
44. Gunt H.B., Miller M.A., Kasting G.B. Water diffusivity in human nail plate. J. Pharm. Sci. 2007, 96:3352-3362.
45. Packer K.J., Sellwood T.C. Proton magnetic resonance studies of hydrated stratum corneum. Part 2. - Self diffusion. J. Chem. Soc. Faraday Trans. 2: Phys. Chem. Condens. Phase. 1978, 74:1592-1606.
46. Hansen J.R., Yellin W. NMR and infrared spectroscopy studies of stratum corneum hydration. Water Structure at the Water-Polymer Interface 1972, 19-28. Plenum Press, New York. H.H.G. Jellinek (Ed.).
47. Foreman M.I. A proton magnetic resonance study of water in human stratum corneum. Biochim. Biophys. Acta 1976, 437:599-603.
48. Johnson M.E., Berk D.A., Blankschtein D., Golan D.E., Jain R.K., Langer R.S. Lateral diffusion of small compounds in human stratum corneum and model lipid bilayer systems. Biophys. J. 1996, 71:2656-2668.
49. Hatcher M.E., Plachy W.Z. Dioxygen diffusion in the stratum corneum: an EPR spin label study. Biochim. Biophys. Acta 1993, 1149:73-78.
50. Mitragotri S. Modeling skin permeability to hydrophilic and hydrophobic solutes based on four permeation pathways. J. Control. Release 2003, 86:69-92.
51. Johnson M.E., Blankschtein D., Langer R. Evaluation of solute permeation through the stratum corneum: lateral bilayer diffusion as the primary transport mechanism. J. Pharm. Sci. 1997, 86:1162-1172.
52. Wang T.-F., Kasting G.B., Nitsche J.M. A multiphase microscopic diffusion model for stratum corneum permeability. II. Estimation of physicochemical parameters, and application to a large permeability database. J. Pharm. Sci. 2007, 96:3024-3051.
53. Roberts W.J., Sloan K.B. Prediction of transdermal flux of prodrugs of 5-fluorouracil, theophylline and 6-mercaptopurine with a series/parallel model. J. Pharm. Sci. 2000, 89:1415-1431.
54. Potts R.O., Guy R.H. Predicting skin permeability. Pharm. Res. 1992, 9:663-669.
55. Yamamoto H., Liljestrand H.M. Partitioning of selected estrogenic compounds between synthetic membrane vesicles and water: effects of lipid components. Environ. Sci. Technol. 2004, 38:1139-1147.
56. Kwon J.H., Liljestrand H.M., Katz L.E. Partitioning of moderately hydrophobic endocrine disruptors between water and synthetic membrane vesicles. Environ. Toxicol. Chem. 2006, 25:1984-1992.
57. Bunge A.L., Cleek R.L. A new method for estimating dermal absorption chemical exposure: 2. Effect of molecular weight and octanol-water partitioning. Pharm. Res. 1995, 12:88-95.
58. Cleek R.L., Bunge A.L. A new method for estimating dermal absorption from chemical exposure. 1. General approach. Pharm. Res. 1993, 10:497-506.
59. Pugh W.J., Roberts M.S., Hadgraft J. Epidermal permeability-penetrant structure relationships: 3. The effect of hydrogen bonding interactions and molecular size on diffusion across the stratum corneum. Int. J. Pharm. 1996, 138:149-165.
60. Roberts M.S., Pugh W.J., Hadgraft J. Epidermal permeability: penetrant structure relationships. 2. The effect of H-bonding groups in penetrants on their diffusion through the stratum corneum. Int. J. Pharm. 1996, 132:23-32.
61. Anderson B.D., Higuchi W.I., Raykar P.V. Heterogeneity effects on permeability-partition coefficient relationships in human stratum corneum. Pharm. Res. 1988, 5:566-573.
62. M.E. Johnson, Biophysical aspects of transdermal drug delivery and chemical enhancement, in: Ph.D. Thesis in Chemical Engineering, Massachusetts Institute of Technology, Cambridge, 1996.
63. Mitragotri S. In situ determination of partition and diffusion coefficients in the lipid bilayers of stratum corneum. Pharm. Res. 2000, 17:1026-1029.
64. Wang L., Chen L., Lian G., Han L. Determination of partition and binding properties of solutes to stratum corneum. Int. J. Pharm. 2010, 398:114-122.
65. Anderson B.D., Raykar P.V. Solute structure-permeability relationships in human stratum corneum. J. Invest. Dermatol. 1989, 93:280-286.
66. Hansen D., Selzer U.F., Schaefer G.B. Kasting, An extended database of keratin binding. J. Pharm. Sci. 2010, 100(5):1712-1726.
67. Kasting G.B., Barai N.D., Wang T.F., Nitsche J.M. Mobility of water in human stratum corneum. J. Pharm. Sci. 2003, 92:2326-2340.
68. Lieb W.R., Stein W.D. Biological membranes behave as non-porous polymeric sheets with respect to the diffusion of non-electrolytes. Nature 1986, 224:240-243.
69. Kasting G.B., Smith R.L., Cooper E.R. Effect of lipid solubility and molecular size on percutaneous absorption. Pharmacology and the Skin 1987, 138-153. Karger, Basel. B. Schroot, H. Schaefer (Eds.).
70. Kumins C.A., Kwei T.K. Free volume and other theories. Diffusion in Polymers 1968, 107-125. Academic Press, New York. J. Crank (Ed.).
71. Poulin P., Krishnan K. Molecular structure-based prediction of human abdominal skin permeability coefficients for several organic compounds. J. Toxicol. Environ. Health A 2001, 62:143-159.
72. Scheuplein R.J., Blank I.H. Permeability of the skin. Physiol. Rev. 1971, 51:702-747.
73. Albery W.J., Hadgraft J. Percutaneous absorption: in vivo experiments. J. Pharm. Pharmacol. 1979, 31:140-147.
74. Leo A., Hansch C., Elkins D. Partition coefficients and their uses. Chem. Rev. 1971, 71:525-616.
75. Saffman P.G., Delbruck M. Brownian motion in biological membranes. Proc. Natl. Acad. Sci. U. S. A. 1975, 72:3111-3113.
76. Vaz W.L.C., Criado M., Madeira V.M.C., Schoellmann G., Jovin T.M. Size dependence of the translational diffusion of large integral membrane proteins in liquid-crystalline phase lipid bilayers. A study using fluorescence recovery after photobleaching. Biochem. 1982, 21:5608-5612.
77. Chen L., Lian G., Han L. Modeling transdermal permeation. Part I. Predicting skin permeability of both hydrophobic and hydrophilic solutes. AIChE J. 2010, 56:1136-1146.
78. Nitsche J.M., Frederick Frasch H. Dynamics of diffusion with reversible binding in microscopically heterogeneous membranes: general theory and applications to dermal penetration. Chem. Eng. Sci. 2011, 66:2019-2041.
79. Illel B., Schaefer H., Wepierre J., Doucet O. Follicles play an important role in percutaneous absorption. J. Pharm. Sci. 1991, 80:424-427.
80. Otberg N., Patzelt A., Rasulev U., Hagemeister T., Linscheid M., Sinkgraven R., Sterry W., Lademann J. The role of hair follicles in the percutaneous absorption of caffeine. Br. J. Clin. Pharmacol. 2008, 65:488-492.
81. Schneider M., Stracke F., Hansen S., Schaefer U.F. Nanoparticles and their interactions with the dermal barrier. Dermatoendocrinol. 2009, 1:197-206.
82. Hansen S., Lehr C.-M. Nanoparticles for transcutaneous vaccination. Microb. Biotechnol. 2011, 5(2):156-167.
83. Lundstrom A., Serre G., Haftek M., Egelrud T. Evidence for a role of corneodesmosin, a protein which may serve to modify desmosomes during cornification, in stratum corneum cell cohesion and desquamation. Arch. Dermatol. Res. 1994, 286:369-375.
84. Lundstrom A., Serre G., Haftek M., Egelrud T. Evidence for a role of corneodesmosin, a protein which may serve to modify desmosomes during cornification, in stratum corneum cell cohesion and desquamation. Arch. Dermatol. Res. 1994, 286:369-375.
85. Bommannan D., Potts R.O., Guy R.H. Examination of stratum corneum barrier function in vivo by infrared spectroscopy. J. Invest. Dermatol. 1990, 95:403-408.
86. Potts R.O., Francoeur M.L. Lipid biophysics of water loss through the skin. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:3871-3873.
87. Mueller B., Anissimov Y.G., Roberts M.S. Unexpected clobetasol propionate profile in human stratum corneum after topical application in vitro. Pharm. Res. 2003, 20:1835-1837.
88. Caspers P.J., Lucassen G.W., Bruining H.A., Puppels G.J. Automated depth-scanning confocal microspectrometer for rapid in-vivo determination of water concentration profiles in human skin. J. Raman Spectros. 2000, 31:813-818.
89. Kasting G.B., Miller M.A., Talreja P. Evaluation of stratum corneum heterogeneity. Percutaneous Absorption 2005, 193-212. Taylor & Francis, New York. R.L. Bronaugh, H. Maibach (Eds.).
90. Kalia Y.N., Alberti I., Naik A., Guy R.H. Assessment of topical bioavailability in vivo: the importance of stratum corneum thickness. Skin Pharmacol. Appl. Skin Physiol. 2001, 14:82-86.
91. George K., Kubota K., Twizell E.H. A two-dimensional mathematical model of percutaneous drug absorption. Biomed. Eng. Online 2004, 3.
92. Ray Chaudhuri S., Kasting G.B., Krantz W.B. Percutaneous absorption of volatile solvents following transient liquid exposures: I. Model development. Chem. Eng. Sci. 2009, 64:1027-1035.
93. Ray Chaudhuri S., Gajjar R.M., Krantz W.B., Kasting G.B. Percutaneous absorption of volatile solvents following transient liquid exposures II. Ethanol. Chem. Eng. Sci. 2009, 64:1665-1672.
94. Kretsos K., Kasting G.B., Nitsche J.M. Distributed diffusion-clearance model for transient drug distribution within the skin. J. Pharm. Sci. 2004, 93:2820-2835.
95. Kretsos K., Miller M.A., Zamora-Estrada G., Kasting G.B. Partitioning, diffusivity and clearance of skin permeants in mammalian dermis. Int. J. Pharm. 2008, 346:64-79.
96. Frasch H.F., Barbero A.M. Steady-state flux and lag time in the stratum corneum lipid pathway: result from finite element models. J. Pharm. Sci. 2003, 92:2196-2207.
97. Barbero A.M., Frasch H.F. Modeling of diffusion with partitioning in stratum corneum using a finite element model. Ann. Biomed. Eng. 2005, 33:1281-1292.
98. Barbero A.M., Frasch H.F. Transcellular route of diffusion through stratum corneum: results from finite element models. J. Pharm. Sci. 2006, 95:2186-2194.
99. Heisig M., Lieckfeldt R., Wittum G., Mazurkevich G., Lee G. Non steady-state descriptions of drug permeation through stratum corneum. I. The biphasic brick-and-mortar model. Pharm. Res. 1996, 13:421-426.
100. Chen L.A., Lian G.B., Han L.A. Use of "bricks and mortar" model to predict transdermal permeation: model development and initial validation. Ind. Eng. Chem. Res. 2008, 47:6465-6472.
101. Rim J.E., Pinsky P.M., van Osdol W.W. Using the method of homogenization to calculate the effective diffusivity of the stratum corneum. J. Membr. Sci. 2007, 293:174-182.
102. Feuchter D., Heisig M., Wittum G. A geometry model for the simulation of drug diffusion through the stratum corneum. Comput. Vis. Sci. 2006, 9:117-130.
103. Hansch C., Leo A. Exploring QSAR: Hydrophobic, Electronic and Steric Constants 1995, American Chemical Society.
104. Surber C., Wilhelm K.-P., Hori M., Maibach H.I., Guy R.H. Optimization of topical therapy: partitioning of drugs into stratum corneum. Pharm. Res. 1990, 7:1320-1324.
105. Surber C., Wilhelm K.-P., Maibach H.I., Hall L.L., Guy R.H. Partitioning of chemicals into human stratum corneum: implications for risk assessment following dermal exposure. Fundam. Appl. Toxicol. 1990, 15:99-107.
106. Hagedorn-Leweke U., Lippold B.C. Accumulation of sunscreens and other compounds in keratinous substrates. Eur. J. Pharm. Biopharm. 1998, 46:215-221.
107. Sobue S., Sekiguchi K., Nabeshima T. Intracutaneous distributions of fluconazole, itraconazole, and griseofulvin in Guinea pigs and binding to human stratum corneum. Antimicrob. Agents Chemother. 2004, 48:216-223.
108. Mohorcic M., Torkar A., Friedrich J., Kristl J., Murdan S. An investigation into keratinolytic enzymes to enhance ungual drug delivery. Int. J. Pharm. 2007, 332:196-201.
109. Romonchuk W.J. Mechanism of enhanced dermal permeation of 4-cyanophenol and methyl paraben from saturated aqueous solutions containing both solutes. Skin Pharmacol. Physiol. 2010, 23:152-163.